Incanthera plc
A therapeutics company developing targeted solutions for dermatology and oncology.
INC | Aquis Stock Exchange
Overview
Corporate Details
- ISIN(s):
- GB00BGL7YW15 (+1 more)
- LEI:
- 2138002HEV4UFBOEXQ97
- Country:
- United Kingdom
- Address:
- C/O GATELEY LEGAL, M2 4WU MANCHESTER
- Website:
- https://incanthera.com/
- Sector:
- Manufacturing
Description
Incanthera plc is a therapeutics company specializing in the discovery and development of targeted solutions for dermatology and oncology. The company develops and applies sophisticated formulation and delivery technologies to create novel treatments. Its pipeline includes clinical-stage oncology assets intended for licensing to pharmaceutical partners. Incanthera has also commercialized its dermatological expertise through its direct-to-consumer skincare brand, Skin+CELL, which is designed to address unmet needs in the skincare market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-29 08:00 |
Appointment of Company Secretary
|
English | 14.1 KB | ||
| 2021-04-23 11:09 |
Holding(s) in Company
|
English | 49.5 KB | ||
| 2021-04-19 08:00 |
Directors Dealings
|
English | 35.5 KB | ||
| 2021-04-16 08:00 |
Grant of Options
|
English | 34.0 KB | ||
| 2021-04-12 13:34 |
Result of GM
|
English | 12.1 KB | ||
| 2021-04-01 08:00 |
Company Webinar Presentation
|
English | 11.7 KB | ||
| 2021-03-23 08:00 |
Placing to Raise £1,144,650
|
English | 15.6 KB | ||
| 2021-02-25 08:00 |
Commercial Update
|
English | 13.7 KB | ||
| 2020-12-14 09:00 |
Designation into new Apex market
|
English | 20.2 KB | ||
| 2020-12-08 08:00 |
Half-year Report
|
English | 143.7 KB | ||
| 2020-12-04 17:08 |
Notice of Interim Results
|
English | 14.6 KB | ||
| 2020-09-29 08:00 |
Completion of Subscription Agreements
|
English | 32.3 KB | ||
| 2020-09-28 08:00 |
Successful Results of Sensitisation Study
|
English | 10.0 KB | ||
| 2020-09-22 08:00 |
Successful Results of Permeation Study
|
English | 12.1 KB | ||
| 2020-07-28 08:00 |
New Patent Filing for Sol Skin Cancer Technology
|
English | 12.2 KB |
Automate Your Workflow. Get a real-time feed of all Incanthera plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Incanthera plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Incanthera plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
